SHS Capital and LPs Invest ~€10M in Develco Pharma
October 7, 2024
SHS Capital, together with its limited partners and other existing shareholders, is investing approximately €10 million in Develco Pharma to expand manufacturing capacity and accelerate product development in response to exceptionally strong demand. Develco, a specialty pharma developer and manufacturer of modified-release formulations headquartered in Pratteln (DACH region), has been backed by SHS since 2020 and reports an order book exceeding 12 months of revenue.
- Buyers
- SHS Capital, SHS Capital limited partners, Other shareholders
- Targets
- Develco Pharma
- Industry
- Pharmaceuticals
- Location
- Basel-Landschaft, Switzerland
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
SHS Invests in Develco Pharma
December 17, 2020
Pharmaceuticals
Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH is making a minority growth investment from its SHS V fund in Swiss-German specialty drug company Develco Pharma. Develco, headquartered in Pratteln, Switzerland with ~125 employees and production in Schopfheim, Germany, develops and manufactures orally administered prolonged-release medicines and will use the investment to broaden its pipeline and expand capabilities.
-
1315 Capital Backs USpharma Ltd. with Growth Equity Investment
June 30, 2025
Pharmaceuticals
USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.
-
GHO Capital and Partners Group Invest in Sterling Pharma Solutions
May 25, 2023
Pharmaceuticals
GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.
-
SHS Capital and ING Corporate Investments Acquire Majority Stake in CAM Bioceramics
July 7, 2023
Medical Devices
German healthcare specialist investor SHS Capital, together with ING Corporate Investments and several co-investors, acquired a majority stake in CAM Bioceramics B.V., a Leiden-based contract development and manufacturing organization (CDMO) for orthobiologic calcium phosphate solutions. Existing owners rolled over a significant stake and management remains in place; the transaction aims to strengthen the business and accelerate investment in people, capabilities and customer partnerships to drive growth.
-
SHS Capital Invests €18M in MESI Medical
June 22, 2023
Medical Devices
Tübingen-based healthcare investor SHS (SHS Gesellschaft für Beteiligungsmanagement mbH) has invested €18 million in MESI, a Slovenian medtech company that develops the MESI mTABLET digital diagnostic platform. The growth capital will be used to expand MESI’s sales organization and product portfolio — including AI-powered predictive applications — to accelerate adoption across primary care, assisted care and other healthcare settings.
-
Impilo and SHS Capital Acquire Lowenco A/S
February 3, 2022
Medical Devices
Nordic investor Impilo and German healthcare-focused investor SHS Capital acquired Lowenco A/S from its founder and owners. Lowenco, headquartered in Vamdrup, Denmark, manufactures modular ultra-low temperature (ULT) storage solutions for the biopharma and pharmaceutical industries; management remains in place and Michael Berg will be appointed chairman of the board.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.